Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/20/2018.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-1746-10
- Dosage Form
- Injection
- Presentation
- Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10)
- Initial Posting
- 02/20/2018
- Revised Date